First-Line Treatment for Croup
Administer a single dose of oral dexamethasone 0.15-0.6 mg/kg (maximum 10 mg) to all children presenting with croup, regardless of severity. This is the cornerstone of croup management and should be given immediately upon diagnosis 1, 2.
Immediate Assessment and Treatment Algorithm
Step 1: Confirm Diagnosis
Look for the classic triad:
- Barky/seal-like cough
- Inspiratory stridor
- Hoarse voice
- Respiratory distress with or without intercostal retractions
Step 2: Assess Severity
Mild Croup:
- Stridor only when agitated or active
- No or minimal retractions
- Child appears comfortable at rest
Moderate-to-Severe Croup:
- Stridor at rest
- Intercostal retractions present
- Increased work of breathing
- Agitation or decreased level of consciousness
Step 3: Administer Corticosteroids
For ALL severities: Give dexamethasone 0.15-0.6 mg/kg orally (single dose). The evidence shows 0.15 mg/kg is as effective as higher doses 2, 3. Dexamethasone reduces return visits by approximately 45% and shortens hospital stays 2.
If child cannot tolerate oral medication: Use nebulized budesonide 2 mg as an alternative 4.
Step 4: Add Nebulized Epinephrine for Moderate-to-Severe Cases
Indications for nebulized epinephrine:
- Stridor at rest with retractions
- Significant respiratory distress
- Need to stabilize before transfer
Dosing options:
- Racemic epinephrine: 0.5 mL/kg of 2.25% solution (maximum 0.5 mL) in 2 mL normal saline 1
- L-epinephrine (if racemic unavailable): 0.5 mL/kg of 1:1000 solution (maximum 5 mg) 5, 1
Critical caveat: Epinephrine's effect lasts only 1-2 hours 5. Children receiving epinephrine must be observed for at least 2-3 hours after administration, as symptoms may recur when the medication wears off. Do not discharge children shortly after epinephrine administration 5.
Observation and Disposition Guidelines
Discharge criteria:
- Mild croup treated with dexamethasone alone
- No stridor at rest after observation period
- Adequate oral intake
- Reliable caregiver
Admit or extend observation if:
- Required 3 doses of nebulized epinephrine 6
- Persistent stridor at rest despite treatment
- Respiratory distress continues
- Concerns about airway compromise
Recent evidence suggests limiting hospital admission until 3 doses of racemic epinephrine are needed reduces admissions by 37% without increasing readmissions 6.
What NOT to Do
Avoid these common pitfalls:
- Do NOT use humidified air or cool mist therapy - no demonstrable benefit in acute settings 3
- Do NOT routinely order lateral neck radiographs - diagnosis is clinical 6
- Do NOT use antibiotics - croup is viral 7
- Do NOT use inhaled corticosteroids (ICS) for acute croup - they are ineffective for this indication 8. Nebulized budesonide is different from maintenance ICS and can be used if oral steroids cannot be given 4
- Do NOT discharge patients immediately after epinephrine without adequate observation 5
Evidence Quality and Nuances
The evidence for corticosteroids in croup is robust, with high-certainty evidence showing benefit at 2 and 6 hours post-treatment 2. The Cochrane review demonstrates glucocorticoids reduce croup scores significantly and decrease return visits by approximately half when comparing dexamethasone to placebo.
Regarding dose, while traditional teaching recommended 0.6 mg/kg dexamethasone, high-certainty evidence now shows 0.15 mg/kg is equally effective for reducing return visits and hospital admissions 2. The lower dose may reduce potential adverse effects while maintaining efficacy.
The British Thoracic Society and European Respiratory Society guidelines both emphasize that nebulized steroids (budesonide 500 μg to 2 mg) may reduce symptoms in the first 2 hours but should be reserved for children who cannot take oral medications 5, 8.